Evidence map›Paper›PMID 29021256›Full record

ArticleThe Journal of biological chemistry2017

Disruption of amyloid precursor protein ubiquitination selectively increases amyloid β (Aβ) 40 levels via presenilin 2-mediated cleavage.

Rebecca L Williamson, Karine Laulagnier, André M Miranda, Marty A Fernandez, Michael S Wolfe, Rémy Sadoul, Gilbert Di Paolo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Negative interplay between HIV-1 Gag and amyloid precursor protein centers around competition for VPS4A and TSG101.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Rebecca L WilliamsonFrom the Department of Pathology and Cell Biology and.
Karine Laulagnierthe Grenoble Institut des Neurosciences, Inserm, Grenoble 38042, France.
André M MirandaFrom the Department of Pathology and Cell Biology and.
Marty A Fernandezthe Center for Neurologic Diseases, Harvard University, Boston, Massachusetts 02115.
Michael S Wolfethe Center for Neurologic Diseases, Harvard University, Boston, Massachusetts 02115.
Rémy Sadoulthe Grenoble Institut des Neurosciences, Inserm, Grenoble 38042, France.
Gilbert Di PaoloFrom the Department of Pathology and Cell Biology and gd2175@cumc.columbia.edu.
Center for Neuro-Oncology · USColumbia University Irving Medical Center · USGrenoble Institute of Neurosciences · FRHarvard University · USInserm · FRUniversity of Minho · PT

Funding

TRANSGENICS AND PRESENILIN FUNCTIONP01AG015379 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI TANZI, RUDOLPH EMILE · 1998 to 2023
$51.3M
Role of phospholipids in membrane traffic at the synapseR01NS056049 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LIEM, RONALD K. · 2006 to 2016
$3.7M
APP ubiquitination and implications for AB generationF30AG047748 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WILLIAMSON, REBECCA LYNN · 2014 to 2017
$180k
NIA NIH HHS F30 AG047748NIA NIH HHS P01 AG015379NINDS NIH HHS R01 NS056049
6 · The paper itself

Abstract

Amyloid plaques, a neuropathological hallmark of Alzheimer's disease, are largely composed of amyloid β (Aβ) peptide, derived from cleavage of amyloid precursor protein (APP) by β- and γ-secretases. The endosome is increasingly recognized as an important crossroad for APP and these secretases, with major implications for APP processing and amyloidogenesis. Among various post-translational modifications affecting APP accumulation, ubiquitination of cytodomain lysines may represent a key signal controlling APP endosomal sorting. Here, we show that substitution of APP C-terminal lysines with arginine disrupts APP ubiquitination and that an increase in the number of substituted lysines tends to increase APP metabolism. An APP mutant lacking all C-terminal lysines underwent the most pronounced increase in processing, leading to accumulation of both secreted and intracellular Aβ40. Artificial APP ubiquitination with rapalog-mediated proximity inducers reduced Aβ40 generation. A lack of APP C-terminal lysines caused APP redistribution from endosomal intraluminal vesicles (ILVs) to the endosomal limiting membrane, with a subsequent decrease in APP C-terminal fragment (CTF) content in secreted exosomes, but had minimal effects on APP lysosomal degradation. Both the increases in secreted and intracellular Aβ40 were abolished by depletion of presenilin 2 (PSEN2), recently shown to be enriched on the endosomal limiting membrane compared with PSEN1. Our findings demonstrate that ubiquitin can act as a signal at five cytodomain-located lysines for endosomal sorting of APP. They further suggest that disruption of APP endosomal sorting reduces its sequestration in ILVs and results in PSEN2-mediated processing of a larger pool of APP-CTF on the endosomal membrane.

Indexed as

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorArginineCell LineEndosomesHumansLysineMutationPeptide FragmentsPresenilin-2ProteolysisUbiquitinationAmyloid beta-Peptidesamyloid beta-protein (1-40)Amyloid beta-Protein PrecursorArginineLysinePeptide FragmentsPresenilin-2PSEN2 protein, humanAlzheimer diseaseamyloid precursor protein (APP)amyloid-β (Aβ)endosomeintracellular processingintracellular traffickinglysosomepresenilinubiquitination

Identifiers

PMID29021256
PMCPMC5712626
OpenAlexW2761997255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.